Dodecapeptide Synthesis Preventing Dimerization via Solvent Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of peptides like NX210, containing cysteine and tryptophan, is challenging due to oligomerization and cyclization issues, and the use of conventional protective groups leads to reactive intermediates, making it difficult to achieve high purity and prevent dimerization and oligomerization during peptide synthesis.
Innovation Solution
Maintaining the peptide in an aqueous solution with an organic solvent, such as acetonitrile, throughout purification and drying steps, particularly using specific protective groups and deprotection cocktails like trifluoroacetic acid with 1,4-dithiothreitol, to minimize the formation of cyclic forms and dimerization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional protective groups (pmc or Mtr) are used for arginine residues, then the peptide synthesis can proceed, but highly reactive intermediates are formed during deprotection that react with other amino acid side chains and require incompatible reaction times
Solution Approach 1:
The patent changes the chemical parameters of the protective groups by using Pbf (phenylmethylsulfonyl) instead of conventional pmc or Mtr groups. This parameter change eliminates the formation of highly reactive intermediates during deprotection, as Pbf releases arginine without generating the problematic intermediates that react with other amino acid side chains.
Solution Approach 2:
The patent converts the potentially harmful effect of arginine side chain reactivity into a benefit by using Pbf protective group. The deprotection of Pbf yields arginine in a controlled manner without generating harmful intermediates, actually improving the synthesis process by eliminating the need for extended reaction times to manage reactivity.
2Ease of manufacture
If trifluoroacetic acid is used for deprotection, then the peptide can be cleaved from resin, but cysteine and tryptophan residues are degraded due to sensitivity to acidic conditions
Solution Approach 1:
The patent introduces an intermediary substance - a specific deprotection cocktail containing trifluoroacetic acid, water, and a thiol compound (such as 1,2-ethanedithiol or thioanisole). The thiol compound acts as a mediator that protects cysteine residues from acid-mediated oxidation and degradation while allowing the deprotection process to proceed. This intermediary enables the use of acidic conditions without the harmful effects on sensitive residues.
Solution Approach 2:
The patent applies beforehand cushioning by adding thiol compounds to the deprotection mixture before the acidic conditions can harm cysteine and tryptophan residues. The thiol compounds preemptively protect these sensitive residues from oxidation and degradation, cushioning them against the harmful effects of trifluoroacetic acid during the cleavage process.
3Ease of manufacture
If the peptide is dried without organic solvent present, then the drying process is simple, but dimerization and oligomerization occur during concentration and drying
Solution Approach 1:
The patent changes the physical-chemical parameters of the solution by maintaining a specific composition of organic solvent (acetonitrile) and water during the concentration and drying process. This parameter change prevents dimerization and oligomerization by controlling the solvent environment, allowing the peptide to remain in monomeric form even during concentration. The organic solvent acts as a diluent that prevents aggregation while still allowing effective concentration.
4Adaptability or versatility
If multiple problematic amino acids (cysteine, tryptophan, arginine) are present, then the peptide has desired biological properties, but the choice of deprotection cocktail becomes far from trivial and purity control becomes difficult
Solution Approach 1:
The patent develops a universal deprotection cocktail formulation that can handle multiple problematic amino acids simultaneously. The cocktail containing trifluoroacetic acid, water, and thiol compounds serves multiple functions: it cleaves the peptide from resin, deprotects arginine (via Pbf group), and protects cysteine and tryptophan from degradation. This multi-functional approach simplifies the selection process compared to using separate specialized reagents for each amino acid type.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively prevents the formation of side products and maintains high purity of NX210, ensuring the peptide's efficacy and safety for therapeutic use by controlling dimerization and oligomerization during the synthesis process.
Implementation Method 1
the peptide of SEQ ID NO: 1 is constantly maintained in an aqueous solution comprising an organic solvent throughout the steps of purification, optional concentration and drying
Implementation Method 2
the latter step being advantageously performed by freeze-drying or spray-drying
Implementation Method 3
the mixture of trifluoroacetic acid (88% v/v), triisopropylsilane (2% v/v), 1,4-dithiothreitol (5% w/v) and water (5% w/w) (Reagent L)
Data Source
AI summary
The invention concerns an improved process for the preparation of the dodecapeptide NX210 of SEQ ID NO: 1 in which the formation of side products is minimized.